Chargement en cours...

Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are increasingly used for advanced lung cancer, but few studies have reported on patient-reported outcomes (PROs) outside the context of a clinical trial. The goal of the current study was to assess PROs in patients participating in the GO(2) Found...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Jim, Heather S. L., Eisel, Sarah L., Hoogland, Aasha I., Shaw, Sandra, King, Jennifer C., Dicker, Adam P.
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795027/
https://ncbi.nlm.nih.gov/pubmed/33396286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010103
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!